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Abstract
The aim of this study was to explore a gene chip capable of detecting the presence of Mycobacterium tuberculosis isolates directly in clinical
sputum specimens and to compare it with current molecular detection techniques. At ﬁrst, we selected 13 M. tuberculosis-speciﬁc target
genes to construct a gene chip for rapid diagnosis. Using the membrane array method, we diagnosed M. tuberculosis by gene chip directly
from 246 sputum specimens from patients suspected of having tuberculosis. Among 80 M. tuberculosis complex (MTBC) culture-positive
sputum specimens, the MTBC detection rate was 62.5% (50/80) by PCR–restriction fragment length polymorphism (RFLP), 70% (56/80)
by acid-fast staining, and 85% (68/80) by the membrane array method. Furthermore, subspecies showed different gene expression
patterns in the membrane array. In conclusion, MTBC could be detected directly in sputum by the membrane array method. The rapidity
of detection and the capability of differentiating subspecies could make this method useful in the control and prevention of tuberculosis.
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Introduction
Globally, Mycobacterium tuberculosis remains one of the major
causes of death due to a single infectious agent. There are
an estimated eight million new cases annually, of which
approximately 3.5 million are infectious (smear-positive)
[1,2]. The incidence differs among countries, depending on
social and economic resources, but the vast majority of
tuberculosis (TB) patients live in developing countries [3].
The impact is felt most in the developing countries of Asia
and Africa, where 95% of cases and 98% of deaths are attrib-
utable to the disease [4]. Rapid and reliable laboratory tests
for the detection, identiﬁcation and determination of the sus-
ceptibility of mycobacteria are crucial for TB control.
Detection of M. tuberculosis complex (MTBC) generally
relies on a combination of in vitro cultivation and staining of
acid-fast bacilli on unprocessed sputum smears with conven-
tional light microscopy [4]. However, the sensitivity has been
variable (range of 20–80%) [5]. Even in well-equipped clinical
laboratories, approximately 3 weeks are required for the
detection of TB cases using liquid culturing systems [6].
With the advent of molecular biological techniques, there
have been signiﬁcant advances in DNA ampliﬁcation and
hybridization that are helping to rectify existing ﬂaws in the
diagnosis of TB. The detection of mycobacterial DNA in
clinical samples by PCR is a promising approach for the rapid
diagnosis of TB. The PCR targets analysed in those samples
include IS6110 [7].
A PCR–restriction fragment length polymorphism (RFLP)
analysis of the hsp65 gene was used for the routine
identiﬁcation of MTBC [8]. However, although PCR and PCR-
RFLP analysis can detect the presence of MTBC, they cannot
differentiate M. tuberculosis from other MTBC members.
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Serological tests have been attempted for decades. It has
been difﬁcult to develop an ELISA utilizing a suitable antigen,
because TB shares a large number of antigenic proteins with
other microorganisms that may or may not be pathogenic.
Meta-analyses have convincingly shown that existing com-
mercial antibody-based tests have limited clinical utility [9].
In previous studies, we used a well-established membrane
array platform for multi-target detection. With this method
[10,11], we analysed MTBC-associated mRNA expression in
sputum and compared the consistency and convenience with
that of PCR-RFLP. In order to directly identify the presence of
M. tuberculosis, we selected 13 M. tuberculosis-speciﬁc target
genes (i.e. hsp65, Rv0577, TbD1, Rv3120, Rv2073c, Rv1970,
Rv3875, Rv0186, Rv0124, Rv3347c, Rv1510, mtp40, and
mpb83) within the regions of difference of the bacterium. They
were marked as M. tuberculosis-speciﬁc targets in the litera-
ture, in genomic databases, and in Medline [12–20]. We used
PCR to construct the M. tuberculosis pattern as a reference.
Using the membrane array method, we constructed the proto-
type of the diagnostic chip with 13 M. tuberculosis-speciﬁc tar-
get genes, and diagnosed TB through the examination of newly
constructed multiple genetic targets directly from sputum
specimens of TB patients. We obtained 246 sputum specimens
from patients suspected of having TB, and applied PCR and
PCR-RFLP to the genotyping of each of the Mycobacterium spe-
cies. The genetic expression proﬁle obtained with the diagnos-
tic chip was fully matched with the PCR pattern of the
candidate genes.
This molecular diagnostic method is not only easy to
apply, but also allows for direct detection of bacteria in the
sputum specimen. The MTBC detection rate with the mem-
brane array is higher than that obtained with PCR-RFLP. The
establishment of the diagnostic gene chip could speed up the
whole process of diagnosing TB and may have great potential
for clinical application.
Materials and Methods
Sample collection of clinical experiments
A total of 246 clinical sputum specimens were obtained
from patients suspected of having TB, at the Kaohsiung
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FIG. 1. PCR products from Mycobacterium samples obtained with with hsp65 and IS6110 probes and results of BstE-generated and HaeIII-gener-
ated restriction fragment length polymorphism (RFLP) patterns. Two sets of oligonucleotide primers were used to amplify target DNA from the
multiple-copy hsp65 gene and IS6110. A 440-bp fragment of hsp65 was ampliﬁed by PCR using primers TB11 and TB12. A 542-bp fragment of
IS6110 was ampliﬁed by PCR using primers MT1007 and MT1008. The PCR products were analysed by electrophoresis on a 3% agarose gel
stained with ethidium bromide, and examined for the presence of 440-bp and 542-bp fragments under UV irradiation. (a) Cases A, B, C, D and
E were hsp65-positive and IS6110-positive; cases F and G were hsp65-positive and IS6110-negative; case H was hsp65-negative and IS6110-nega-
tive. (b) PCR products were digested with the restriction enzymes BstE and HaeIII in order to identify Mycobacterium tuberculosis complex
(MTBC) and non-tuberculous mycobacteria (NTM) on the basis of the RFLP patterns. Cases A, B, C, D and E were conﬁrmed MTBC. Cases F
and G were NTM. Case H involved another species.
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Medical University Hospital, from December 2006 to July
2007. The exclusion criterion was contamination of the
specimen. Specimen acquisition and subsequent use were
approved by the Institutional Review Board of Kaohsiung
Medical University Hospital. After processing for routine
mycobacteriology [21], each post-decontamination specimen
was divided into two parts: one part (0.5 mL) was used for
smear and culture, and the other (0.5 mL) was processed
for PCR.
Microscopy and culture
Sputum samples were digested and decontaminated, using
the standard protocol, with N-acetyl-L-cysteine/2% NaOH
(pH 6.8). Phosphate buffer was added, bacteria were concen-
trated by centrifugation (3000 g) for 15 min [22], and
sediments were cultured in triplicate at 37C and 10% CO2
on Lo¨wenstein–Jensen slant medium.
The sediment was resuspended in 2 mL of supernatant.
All clinical specimens were processed for direct smear
examination by ﬂuorescence microscopy after Aur-
amine O/Rhodamine B staining for AFB. Aliquots of the
remaining clinical samples and the resuspended sediments of
sputum were frozen at )30C until being processed for PCR.
MTBC strain analysis by PCR and PCR-RFLP
Polymorphic regions of each of the 13 genes (see above)
were ampliﬁed by multiple PCR with two allele-speciﬁc sense
(or antisense) primers. Two sets of oligonucleotide primers
were used to amplify target DNA from the multiple-copy
genes [7]. A 440-bp fragment of hsp65 was ampliﬁed by PCR
using primers TB11 and TB12. A 542-bp fragment of IS6110
was ampliﬁed by PCR using the primers MT1007 and
MT1008. Products were analysed by electrophoresis on a 3%
agarose gel stained with ethidium bromide, and examined for
the presence of 440-bp and 542-bp fragments under UV
irradiation. PCR products were digested with the restriction
enzymes BstE and HaeIII in order to identify MTBC and
non-tuberculous mycobacteria (NTM) on the basis of RFLP
patterns (Fig. 1a,b). Thirteen M. tuberculosis-speciﬁc target
genes were analysed by electrophoresis of PCR products.
Preparation of digoxigenin (DIG)-labeled cDNA targets and
hybridization
First-strand cDNA targets for hybridization were produced
using SuperScript reverse transcriptase (Gibco-BRL,
Gaithersburg, MD, USA) in the presence of DIG-labeled
UTP (Roche Diagnostics GmbH, Penzberg, Germany). After
the prehybridization procedure, the gene chips were sub-
jected to hybridization. The arrays were covered with
Express Hyb Hybridization Solution (BD Biosciences, Palo
Alto, CA, USA) containing DIG-11-UTP-labeled cDNA
probes, and then incubated with alkaline phosphatase-conju-
gated anti-DIG antibody (Roche Diagnostics) and blocking
solution. For hybridization, the arrays were incubated at
42C for 12 h in a humid chamber. After washing, the
arrays were exposed to light. For signal detection, the gene
chips were incubated in chromogen solution containing
nitroblue tetrazolium and 5-bromo-4-chloro-3-indoyl-
phosphate for 15 min.
Design of oligonucleotide probes and preparation of the
oligonucleotide membrane array
The procedure for the design and preparation of the mem-
brane array was in accordance with our recent work [23].
Visual OMP3 (Oligonucleotide Modeling Platform; DNA Soft-
ware, Ann Arbor, MN, USA) was used to design probes
(Table 1). The probe selection criteria included strong mis-
match discrimination, minimal or no secondary structure, sig-
nal strength at the assay temperature, and lack of cross-
hybridization. Probes were synthesized according to the
designed sequences, puriﬁed and controlled before being
grafted onto the substrates. The newly synthesized oligonu-
cleotides were dissolved in distilled water at a concentration
of 20 mM, and applied to a BioJet Plus 3000 nanolitre
dispenser system (BioDot, Irvine, CA, USA), which blotted
the 13 target gene oligonucleotides (and one housekeeping
TABLE 1. Oligonucleotide probes
for 13 Mycobacterium tuberculosis-
speciﬁc target genes
Gene Oligonucleotide
hsp65 AAAGGTGTTGGACTCCTCGACGGTGATGACGCCCTCGTTGCCCACCTTGT
Rv0577 TCCGTGAGCAGTTCGTTCCAGATGAGCGTGCCCGTCTCGTTGACCAACGT
Rv3120 AATACCGCCTCCGTGGGGTCAGCGCACTCGTATTTCGCGTTCCAACGAAT
Rv2073c GCGTCGTCACTAAGCCGCGTAGTGGTGTTGACCATCGCCACTCACGCTAG
Rv1970 TCTGCTCGGTGCTTGGGTAGGCGCTACCGTGTGACAGCGCAATGAGTGAA
Rv3875 TCCCCTCGTCAAGGAGGGAATGAATGGACGTGACATTTCCCTGGATTGCG
Rv3347c TGGACGCCCCAACGATCCAGTTGTCGCCGAGCGCATTCACGAACAGCAAC
Rv1510 AGTTTGGTAGTCGGGGCCGAATCCAACACGCAGCAACCAGGGACCGGTAA
Rv0186 GTGCCGGTCGGGTACCGCAATAGTGCCTGTGCCGCCATGGTTTTCATAGT
Rv0124 ACCACAATCTCCGGGGCTACGCTGACAAACGACATCACACACCTCCCCAA
TbD1 GTGTCCAGGACTTGCCGAGGTGTGGCATCCACGTCCAGATAATTGATCGT
mtp40 TGGTCGAATTCGGTGGAGTCGCAAAGTTGAACGCTGAGGTCATGTCGCCA
mpb83 TGCGACACGGGTTTGGTGCTCGAACAACCCGCTAAGAACGCAATCGCGAT
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gene, b-actin) sequentially (50 nL per spot; 1.5 mm between
spots) onto a Nytranl SuperCharge nylon membrane (Schlei-
cher and Schuell, Dassel, Germany) in triplicate; the oligonu-
cleotides were cross-linked to the membrane using a UV
Stratalinker 1800 (Statagene, La Jolla, CA, USA). Each spot
contained 20 ng of PCR-ampliﬁed DNA derived from
sequence-veriﬁed cDNA clones. Dimethylsulphoxide was
also dispensed onto the membrane as a blank control.
Data analysis of colourimetric membrane
The hybridized arrays were scanned with an Epson Perfec-
tion 1670 ﬂatbed scanner (SEIKO EPSON Corp., Nagano-
ken, Japan). Subsequent quantitative analysis of the intensity
of each spot was performed using AlphaEase FC software
(Alpha Innotech Corp., San Leandro, CA, USA). Spots of
consistently two fold (or greater) increased intensity with
respect to positive control were considered to represent dif-
ferentially expressed genes. These array analysis tools facili-
tated the measurement of relative grey levels of objects in a
uniformly spaced array, such as in dot blots. A deformable
template extracted the gene spots and quantiﬁed their
expression levels according to the integrated intensity of
each spot after background subtraction.
The fold ratio for each gene was calculated as follows:
spot intensity ratio = mean intensity of target gene/mean
intensity of b-actin. Fig. 2a shows a schematic representa-
tion of the membrane array with 13 target genes, one
housekeeping gene (b-actin), and one blank control. The
positions of the target genes and the correlation between
the blank and positive control (b-actin) on the nylon mem-
brane are indicated by spots. A triplicate set of molecular
markers were blotted (Fig. 2b). This membrane array was
used to detect the gene expression proﬁles of M. tubercu-
losis-speciﬁc target genes in sputum specimens. Sputum
samples of 3–5 mL were digested and decontaminated, and
1-mL sediment suspensions were subjected to total RNA
extraction and subsequent synthesis of cDNA to be
applied to the membrane.
hsp65 Rv0577 Rv3120 Rv2073c Rv1970 Rv3875 Rv3347c Blank
hsp65 Rv0577 Rv3120 Rv2073c Rv1970 Rv3875 Rv3347c Blank
hsp65 Rv0577 Rv3120 Rv2073c Rv1970 Rv3875 Rv3347c Blank
Blank
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8
Lane 1 : hsp65 ; 2 : Rv0577 ; 3 : Rv3120 ; 4 : Rv2073c ; 5 : Rv1970 ; 6 : Rv3875 ; 7 : Rv3347c ; 8 :
Rv1510 ; 9 : Rv0186 ; 10 : Rv0124 ; 11 : TbD1 ; 12 : mtp40 ; 13 : mpb83 ; B : Blank ; P : b-actin
9 10 11 12 13 B P
Rv0124Rv0186Rv1510
TbD1Rv0124Rv0186Rv1510
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FIG. 2. Array table of the gene chip and gene expression pattern in a Mycobacterium tuberculosis sample. (a) Schematic representation of a mem-
brane array with 13 M. tuberculosis-speciﬁc target genes, one housekeeping gene (b-actin), and a blank control. The positions of 13 M. tuberculosis-
speciﬁc target genes (i.e. hsp65, Rv0577, TbD1, Rv3120, Rv2073c, Rv1970, Rv3875, Rv0186, Rv0124, Rv3347, Rv1510, mtp40 and mpb83), as well as
the correlation between the blank and positive control (b-actin) in the nylon membrane, are indicated by spots. The relevant positions are red (b-
actin), yellow (blank), and blue, green and purple (M. tuberculosis-speciﬁc target genes). (b) Expression patterns of M. tuberculosis-speciﬁc target
genes in one sample of M. tuberculosis; the array results were as follows: hsp65, +; Rv0577, +; TbD1, ); Rv3120, +; Rv2073c, +; Rv1970, +; Rv3875,
+; Rv0186, +; Rv0124, +; Rv3347, +; Rv1510, +; mtp40, +; mpb83, +; b-actin, +.
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Results
The 246 sputum specimens from patients suspected of having
TB were analysed. The results concerning IS6110 and hsp65
of the Mycobacterium isolates were obtained by PCR-RFLP
analysis. Following culture, 80 of 246 specimens were found
to contain MTBC, 155 were identiﬁed as NTM, and 11 were
found to be bacteria other than mycobacteria.
According to the results of the membrane array analysis,
the MTBC subspecies have individual M. tuberculosis-speciﬁc
target gene expression proﬁles, as shown in Table 2. For
example, M. tuberculosis had a >90% positive reaction with
respect to hsp65, Rv0577, Rv3120, Rv2073c, Rv1970, Rv3875,
Rv0186, Rv0124, Rv3347c, Rv1510 and mtp40, whereas Myco-
bacterium bovis had a >90% positive reaction with respect to
hsp65, TbD1, Rv3875, Rv0186, Rv0124, Rv3347c, Rv1510, and
mpb83.
Among these MTBC culture-positive sputum specimens,
56 (70%) were also shown to be smear-positive, PCR-RFLP
was positive in 50 (62.5%), and the membrane array was
positive in 68 (85%). Of the 24 MTBC culture-positive, stain-
negative sputum specimens, 11 (45.8%) tested positive by
PCR-RFLP, and 16 (67%) tested positive by the membrane
array method. The comparative MTBC detection rates
determined using the acid-fast stain, PCR-RFLP method and
membrane array method are shown in Table 3.
Discussion
TB is a bacterial disease caused by MTBC organisms and
continues to be a leading cause of death in developing
countries. It is transmitted primarily by the nuclei of
airborne droplets; however, the diagnosis of TB continues
to pose serious problems, mainly because of difﬁculties in
differentiating between patients with active TB and those
with healed lesions. Physicians still rely on conventional
methods, such as Ziehl–Neelsen staining, ﬂuorochrome
staining, and sputum culture. Although the tuberculin test
has facilitated diagnosis for more than 85 years, its interpre-
tation is difﬁcult, because sensitization with NTM leads to
false-positive test results. Rapid diagnosis and treatment are
important for preventing the transmission of the disease.
Microscopy and culture are still the major backbone of
laboratory diagnosis of TB. However, a positive smear by
Acid-Fast stain (AFS) requires the presence of £104 AFB
per millilitre of sputum, and AFS is unable to identify other
acid-fast organisms [24].
Microscopy with material from solid, and often liquid,
cultures can be used to make a presumptive diagnosis of TB,
although it does not allow a distinction to be made between
M. tuberculosis and NTM in clinical specimens [25]. The ability
to simultaneously assess the smear status and directly distin-
guish between M. tuberculosis and NTM in a clinical specimen
has important implications for patient treatment and hospital
infection control.
The prompt diagnosis of smear-positive cases is a prere-
quisite for controlling TB, and several new methods have
evolved over the past two decades. The majority of molecu-
lar tests have focused on the detection of nucleic acid
sequences in both DNA and RNA speciﬁc for M. tuberculosis
by ampliﬁcation techniques such as PCR. With a smear-
TABLE 2.Mycobacterium tuberculosis-speciﬁc target gene expression proﬁles of individual M. tuberculosis complex subspecies
observed by membrane array analysis
hsp65 Rv0577 TbD1 Rv3120 Rv2073c Rv1970 Rv3875 Rv0186 Rv0124 Rv3347c Rv1510 mtp40 mpb83
M. canettii + + + + + + + + + + + + )
M. tuberculosis + + ) + + + ± + + + + + )
M. africanum Ib + + + + ) + + + + ± + + )
M. africanum IIb + + ± + ) ) + ) ) + + + )
M. microti + + + + ) ) ) + + ) ± + )
M. caprae + + + ) ^ ) + + + + + + )
M. bovis + ± + ) ) ) + + + + + ) +
M. bovis BCG + + + ) ) ^ ) + + + ) ) +
+, positive reaction in >90% of total bacterial isolates; ±, positive reaction in 90–60% of total bacterial isolates; ^, positive reaction in 10–60% of total bacterial isolates; ),
positive reaction in <10% of total bacterial isolates.
TABLE 3. Comparison of 80 Mycobacterium tuberculosis
complex culture-positive sputum specimens by acid-fast
stain, PCR–restriction fragment length polymorphism
(PCRRFLP), and membrane array
PCR-RFLP Membrane array
Positive Negative Positive Negative
Acid-fast stain Positive 39 17 52 4
Negative 11 13 16 8
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negative specimen, however, a negative PCR result does not
exclude the presence of M. tuberculosis [7]. In this study,
among MTBC culture-positive but smear-negative sputum
specimens, PCR-RFLP analysis led to the detection of MTBC
in 45.8% of cases, and the membrane array method in up to
67%. Among the culture-positive and sputum smear-positive
specimens, PCR gave a 70% identiﬁcation rate and the mem-
brane array method was positive in 92.8%. Thus, in this
study, the membrane array method yielded a higher
detection rate than PCR-RFLP for either smear-positive or
smear-negative MTBC sputum culture-positive specimens.
Although the virulence and host ranges differ among
MTBC members, most conventional molecular techniques
are incapable of differentiating among these subspecies,
because of the genetic identities of their 16S rRNA gene
sequences. Parsons et al. [26] reported that the identiﬁca-
tions obtained by using the speciﬁc deletion proﬁles corre-
lated well with the original identiﬁcations for all MTBC
subspecies, except for Mycobacterium africanum. MTBC mem-
bers contain the transposable element IS6110, which has
become a widely used diagnostic marker in epidemiological
studies [27]. However, an IS6110-based PCR assay still does
not allow differentiation among subspecies of MTBC.
In the modern era of genetics, the day is not far off when
chip-based DNA hybridization assays will provide instant
diagnosis of mycobacterial infections. In 2002, Brosch et al.
[14] evaluated the distribution of 20 variable regions result-
ing from insertion–deletion events in the genomes of the
MTBC subspecies. In order to differentiate among the
subspecies, we elected 13 speciﬁc target genes that were
correlated with the regions of difference or marked as
MTBC-speciﬁc targets in the literature, in genomic databases
and in Medline. Using the membrane array method, we
found that there were different M. tuberculosis-speciﬁc target
gene expression proﬁles by examining sputum specimens
directly using gene chip-based analysis.
As the membrane array method is capable of detecting
multiple gene targets simultaneously, it is more efﬁcient, in
terms of time and cost, than PCR [28]. The advantages of
membrane array methods are as follows: (i) simultaneous
analysis of multiple genes is possible; (ii) a small sample is
required, and simultaneous analysis can reduce the consump-
tion of reagents and materials; and (iii) with the use of auto-
mated detection software, the biological molecules can be
analysed within a short time period. However, the gene
chips and ﬂuorescence scanners that are needed to read test
results are still expensive; therefore, the popularity remains
limited. The membrane array method uses the chemical
colourimetric method, which replaces glass chips with the
ﬂuorescence of gene chips, and nylon membranes. The entire
process of hybridization and colour development takes
<12 h in total. The cost (c. $50) and technology thresholds
are thus reduced signiﬁcantly, while the original advantages
of the gene chip are preserved. Although this technique can
signiﬁcantly reduce the difﬁculty and cost of experiments
(and thereby increase its popularity and application in the
medical setting), the reading of colourimetric methods is eas-
ily skewed by artefacts.
Application of membrane assays to the control of TB may
result in important innovations in diagnosis and treatment.
This method has reduced the time to diagnosis, and
increased the safety of laboratory technicians and medical
technologists. Moreover, the MTBC detection rate of the
membrane assay is potentially higher than that of PCR-RFLP
assays. Thus, our goal is to develop a sensitive, time-saving
and high-throughput active TB chip for the detection of
M. tuberculosis. In the future, membrane arrays could be
adapted to drug susceptibility testing. The differential activi-
ties and post-antibiotic effects of various drugs against TB
will lead to highly effective, less time-consuming regimens
and to directly monitored therapy.
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